EFFECTS OF SAPROPTERIN ON PORTAL AND SYSTEMIC HEMODYNAMICS IN PATIENTS WITH CIRRHOSIS AND PORTAL HYPERTENSION: A BICENTRIC DOUBLE-BLIND PLACEBO CONTROLLED STUDY

被引:0
|
作者
Reverter, E. [1 ,2 ]
Mesonero, F. [3 ,4 ]
Seijo, S. [1 ,2 ]
Martinez, J. [3 ,4 ]
Abraldes, J. G. [1 ,2 ]
Penas, B. [3 ,4 ]
Berzigotti, A. [1 ,2 ]
Bosch, J. [1 ,2 ]
Albillos, A. [3 ,4 ]
Garcia-Pagan, J. C. [1 ,2 ]
机构
[1] Hosp Clin Barcelona, Liver Unit, Hepat Hemodynam Lab, IDIBAPS, Barcelona, Spain
[2] Hosp Clin Barcelona, CIBERehd, Barcelona, Spain
[3] Hosp Univ Ramon & Cajal, IRYCIS, Gastroenterol & Hepatol, Alcala De Henares, Spain
[4] CIBERehd, Alcala De Henares, Spain
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P517
引用
收藏
页码:S242 / S242
页数:1
相关论文
共 50 条
  • [31] Computational hemodynamics of portal vein hypertension in hepatic cirrhosis patients
    Li, X.
    Wang, X. K.
    Chen, B.
    Pu, Y. S.
    Li, Z. F.
    Nie, P.
    Su, K.
    BIO-MEDICAL MATERIALS AND ENGINEERING, 2015, 26 : S233 - S243
  • [32] Carvedilol to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by liver stiffness: study protocol for a randomied, double-blind, placebo-controlled, multicentre trial in China
    Liu, Chuan
    Zhang, Liting
    Zhang, Shuairan
    Li, Xiaoguo
    Wong, Yu-Jun
    Liang, Xuan
    Wang, Yan
    Wu, Xiaofeng
    Gou, Wei
    Lv, Jiaojian
    Hu, Shengjuan
    Fu, Junliang
    Huang, Ju
    Ge, Guohong
    Huang, Mingxing
    Wang, Fang
    Zhang, Qingge
    Ren, Tao
    Meng, Zhongji
    Ding, Deping
    Zhuoga, Basang
    Zhuoga, Cidan
    Fan, Jian
    Dang, Dianjie
    Miao, Liang
    Song, Zhaomin
    Xiao, Xingguo
    Wu, Huili
    Jiang, Kai
    Liu, Tianyu
    Gao, Youfang
    Ma, Lan
    Fang, Tao
    Wang, Yuehua
    Zhang, Qianhua
    Zhu, Da
    Ji, Dong
    Cao, Zhujun
    Zeng, Qing-Lei
    Li, Jie
    Chen, Ping
    Wei, Yufang
    Tong, Zhaowei
    Hong, Zhongsi
    Liang, Xiao
    Li, Yiling
    Nan, Yuemin
    Qi, Xiaolong
    BMJ OPEN, 2024, 14 (07): : 1 - 5
  • [33] EFFECTS OF SOMATOSTATIN AND SMS 201-995 ON HEPATIC AND SYSTEMIC HEMODYNAMICS IN PATIENTS WITH CIRRHOSIS AND PORTAL-HYPERTENSION
    JENKINS, SA
    BAXTER, JN
    ELLENBOGEN, S
    SNOWDON, S
    WHITEHOUSE, G
    SHIELDS, R
    GUT, 1988, 29 (05) : A720 - A720
  • [34] SPLANCHNIC AND SYSTEMIC HEMODYNAMICS, HEPATO-CELLULAR INSUFFICIENCY AND PORTAL-HYPERTENSION IN PATIENTS WITH CIRRHOSIS - EFFECTS OF PROPRANOLOL
    LEBREC, D
    ANNALES DE GASTROENTEROLOGIE ET D HEPATOLOGIE, 1987, 23 (07): : 395 - 398
  • [35] EFFECTS OF ACUTE PORTAL-HYPERTENSION BY PORTAL VENOUS STENOSIS ON SYSTEMIC HEMODYNAMICS IN DOGS
    MORIURA, S
    NIMURA, Y
    KATO, M
    SATO, T
    SHIONOYA, S
    EUROPEAN SURGICAL RESEARCH, 1990, 22 (02) : 113 - 119
  • [36] Hemodynamic profile of terlipressin and octreotide in patients with cirrhosis and portal hypertension. A randomized, double-blind clinical trial
    Perez-Campuzano, Valeria
    Olivas, Pol
    Baiges, Anna
    Orts, Lara
    Shalaby, Sarah
    Ojeda, Asuncion
    Turon, Fanny
    Hernandez-Gea, Virginia
    Cardenas, Andres
    Garcia-Pagan, Juan Carlos
    JOURNAL OF HEPATOLOGY, 2024, 80 : S240 - S240
  • [37] Norfloxacin treatment for clinically significant portal hypertension: results of a randomised double-blind placebo-controlled crossover trial
    Kemp, William
    Colman, John
    Thompson, Kenneth
    Madan, Anoop
    Vincent, Margaret
    Chin-Dusting, Jaye
    Kompa, Andrew
    Krum, Henry
    Roberts, Stuart
    LIVER INTERNATIONAL, 2009, 29 (03) : 427 - 433
  • [38] A DOUBLE-BLIND PLACEBO CONTROLLED-STUDY OF KETANSERIN IN HYPERTENSION
    CAMERON, HA
    RAMSAY, LE
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (02) : P275 - P275
  • [39] Probiotics for patients with compensated liver cirrhosis: A double-blind placebo-controlled study
    Pereg, David
    Kotliroff, Andy
    Gadoth, Natan
    Hadary, Ruth
    Lishner, Michael
    Kitay-Cohen, Yona
    NUTRITION, 2011, 27 (02) : 177 - 181
  • [40] EFFECT OF HIGH AND LOW PROTEIN MEALS ON PORTAL HEMODYNAMICS IN PATIENTS WITH CIRRHOSIS AND PORTAL-HYPERTENSION
    AFDHAL, NH
    MCCORMACK, PA
    KEOGHAN, M
    HEGARTY, JE
    HEPATOLOGY, 1987, 7 (05) : 1060 - 1060